The export of vaccines for human use from Switzerland is projected to decrease from $82.429 million in 2024 to $79.785 million in 2028. The year-on-year percentage decrease is consistent, indicating a downward trend. The actual value for 2023 was not provided, but considering the forecasted data, the Compound Annual Growth Rate (CAGR) over the next five years is negative, reflecting a decline.
Key variations:
- 2024 to 2025: -0.83%
- 2025 to 2026: -0.82%
- 2026 to 2027: -0.81%
- 2027 to 2028: -0.80%
Future trends to watch for include changes in global health policies, advancements in vaccine technology, and fluctuations in international market demands. Increasing competition and regulatory changes could also impact Switzerland's vaccine export figures.
Latest reports
US Vaccine Market Report- Q1 2025
The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...
China Vaccine Market Report- Q1 2025
The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...
Japan Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...
Germany Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...
India Vaccine Market Report- Q4 2024
The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...
UK Vaccine Market Report- Q4 2024
The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...
France Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...
Canada Vaccine Market Report- Q4 2024
The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...
Brazil Vaccine Market Report- Q4 2024
The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...
Italy Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...
